Rankings
▼
Calendar
MLTX Q4 2025 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$751,000
Operating Income
-$65M
Net Income
-$62M
EPS (Diluted)
$-0.93
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$59M
Free Cash Flow
-$59M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$424M
Total Liabilities
$120M
Stockholders' Equity
$304M
Cash & Equivalents
$335M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$751,000
$0
—
Operating Income
-$65M
-$50M
-31.5%
Net Income
-$62M
-$46M
-36.9%
← FY 2025
All Quarters